UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Bladder Pain Syndrome - an Evolution

2nd ed. 2018 edition., 2017

Volltextzugriff (PDF)

Blood-Brain Barrier Permeation and Efflux Exclusion of Anticholinergics Used in the Treatment of Overactive Bladder

Drugs & aging, 2012-04, Vol.29 (4), p.259-273

2012

Volltextzugriff (PDF)

Combination Therapy for Overactive Bladder: Who Approves?

European urology, 2018-10, Vol.74 (4), p.510-511

Staskin, David R.

2018

Volltextzugriff (PDF)

Using Anticholinergics to Treat Overactive Bladder: The Issue of Treatment Tolerability

The American journal of medicine, 2006-03, Vol.119 (3), p.9-15

2006

Volltextzugriff (PDF)

Extended-Release Trospium Chloride Improves Quality of Life in Overactive Bladder

Value in health, 2010-03, Vol.13 (2), p.251-257

2010

Volltextzugriff (PDF)

Randomized, Double-blind, Placebo-controlled Trial of Flexible-dose Fesoterodine in Subjects With Overactive Bladder

Urology (Ridgewood, N.J.), 2010, Vol.75 (1), p.62-68

2010

Volltextzugriff (PDF)

Conflict of interest - who benefits?

Neurourology and urodynamics, 2012-11, Vol.31 (8), p.1221-1222

Staskin, David R.

2012

Volltextzugriff (PDF)

Percutaneous Tibial Nerve Stimulation: A Clinically and Cost Effective Addition to the Overactive Bladder Algorithm of Care

Current urology reports, 2012-10, Vol.13 (5), p.327-334

2012

Volltextzugriff (PDF)

Oxybutynin chloride topical gel: a new formulation of an established antimuscarinic therapy for overactive bladder

Expert opinion on pharmacotherapy, 2009-12, Vol.10 (18), p.3103-3111

2009

Volltextzugriff (PDF)

Trospium 60 mg Once Daily (QD) for Overactive Bladder Syndrome: Results from a Placebo-Controlled Interventional Study

Urology (Ridgewood, N.J.), 2008-03, Vol.71 (3), p.449-454

2008

Volltextzugriff (PDF)

Overactive bladder in the elderly : A guide to pharmacological management

Drugs & aging, 2005-01, Vol.22 (12), p.1013-1028

STASKIN, David R

2005

Volltextzugriff (PDF)

Efficacy and Safety of Tolterodine Extended Release and Dutasteride in Male Overactive Bladder Patients With Prostates >30 Grams

Urology (Ridgewood, N.J.), 2010-05, Vol.75 (5), p.1144-1148

2010

Volltextzugriff (PDF)

Trospium chloride once‐daily extended release is efficacious and tolerated in elderly subjects (aged ≥75 years) with overactive bladder syndrome

BJU international, 2011-02, Vol.107 (4), p.612-620

2011

Volltextzugriff (PDF)

A call to action: the compelling need to advance the role of urgency

World journal of urology, 2009-12, Vol.27 (6), p.765-766

Staskin, David R.

2009

Volltextzugriff (PDF)

Cognitive Effects of Oxybutynin Chloride Topical Gel in Older Healthy Subjects: A 1-Week, Randomized, Double-Blind, Placebo- and Active-Controlled Study

Clinical drug investigation, 2012-10, Vol.32 (10), p.707-714

2012

Volltextzugriff (PDF)

Prospective randomized controlled trial of extended-release oxybutynin chloride and tolterodine tartrate in the treatment of overactive bladder: results of the OBJECT Study

Mayo Clinic proceedings, 2001-04, Vol.76 (4), p.358-363

2001

Volltextzugriff (PDF)

Trospium Chloride: Distinct Among Other Anticholinergic Agents Available for the Treatment of Overactive Bladder

Urologic clinics of North America, 2006-11, Vol.33 (4), p.465-473

Staskin, David R.

2006

Volltextzugriff (PDF)

Short‐ and long‐term efficacy of solifenacin treatment in patients with symptoms of mixed urinary incontinence

BJU international, 2006-06, Vol.97 (6), p.1256-1261

2006

Volltextzugriff (PDF)

Prospective Randomized Controlled Trial of Extended-Release Oxybutynin Chloride and Tolterodine Tartrate in the Treatment of Overactive Bladder: Results of the OBJECT Study

Mayo Clinic proceedings, 2001-04, Vol.76 (4), p.358-363

2001

Volltextzugriff (PDF)

Cognitive Effects of Oxybutynin Chloride Topical Gel in Older Healthy Subjects: A 1-Week, Randomized, Double-Blind, Placebo- and Active-Controlled Study

Clinical drug investigation, 2012-10, p.1

2012

Volltextzugriff (PDF)

Advances in female stress urinary incontinence: mid‐urethral slings

BJU international, 2006-09, Vol.98 (s1), p.32-40

2006

Volltextzugriff (PDF)

Once-daily trospium chloride 60 mg extended-release provides effective, long-term relief of overactive bladder syndrome symptoms

Neurourology and urodynamics, 2011-09, Vol.30 (7), p.1214-1219

2011

Volltextzugriff (PDF)

Transdermal delivery of drugs for urologic applications: Basic principles and applications

Urology (Ridgewood, N.J.), 2006-04, Vol.67 (4), p.657-664

2006

Volltextzugriff (PDF)

Re: Giacomo Novara, Antonio Galfano, Silvia Secco, et al. A Systematic Review and Meta-Analysis of Randomized Controlled Trials with Antimuscarinic Drugs for Overactive Bladder. Eur Urol 2008;54:740–64

European urology, 2009-05, Vol.55 (5), p.e84-e85

2009

Volltextzugriff (PDF)

Pharmacologic Management of Overactive Bladder: Practical Options for the Primary Care Physician

The American journal of medicine, 2006-03, Vol.119 (3), p.24-28

2006

Volltextzugriff (PDF)

1 – 25 von 300

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(115)
Mit Volltextzugriff
(270)

Publikationsform

Sprache

Englisch
(300)

Erscheinungsjahr

n.n

Thema

Humans
(74)
Life Sciences & Biomedicine
(69)
Science & Technology
(69)
Urology & Nephrology
(49)
Female
(46)
Urology & Urogenital Medicine
(41)
Male
(33)
Biological And Medical Sciences
(31)
Medical Sciences
(31)
Urology
(31)
Nephrology. Urinary Tract Diseases
(23)
Aged
(21)
Middle Aged
(21)
Urinary System Involvement In Other Diseases. Miscellaneous
(21)
Urinary Tract. Prostate Gland
(21)
Medicine
(20)
Treatment Outcome
(20)
Urinary Incontinence
(20)
Urinary Bladder, Overactive - Drug Therapy
(19)
Muscarinic Antagonists - Therapeutic Use
(18)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Bladder Pain Syndrome - an Evolution

Blood-Brain Barrier Permeation and Efflux Exclusion of Anticholinergics Used in the Treatment of Overactive Bladder

Combination Therapy for Overactive Bladder: Who Approves?

Using Anticholinergics to Treat Overactive Bladder: The Issue of Treatment Tolerability

Extended-Release Trospium Chloride Improves Quality of Life in Overactive Bladder

Randomized, Double-blind, Placebo-controlled Trial of Flexible-dose Fesoterodine in Subjects With Overactive Bladder

Conflict of interest - who benefits?

Percutaneous Tibial Nerve Stimulation: A Clinically and Cost Effective Addition to the Overactive Bladder Algorithm of Care

Oxybutynin chloride topical gel: a new formulation of an established antimuscarinic therapy for overactive bladder

Trospium 60 mg Once Daily (QD) for Overactive Bladder Syndrome: Results from a Placebo-Controlled Interventional Study

Overactive bladder in the elderly : A guide to pharmacological management

Efficacy and Safety of Tolterodine Extended Release and Dutasteride in Male Overactive Bladder Patients With Prostates >30 Grams

Trospium chloride once‐daily extended release is efficacious and tolerated in elderly subjects (aged ≥75 years) with overactive bladder syndrome

A call to action: the compelling need to advance the role of urgency

Cognitive Effects of Oxybutynin Chloride Topical Gel in Older Healthy Subjects: A 1-Week, Randomized, Double-Blind, Placebo- and Active-Controlled Study

Prospective randomized controlled trial of extended-release oxybutynin chloride and tolterodine tartrate in the treatment of overactive bladder: results of the OBJECT Study

Trospium Chloride: Distinct Among Other Anticholinergic Agents Available for the Treatment of Overactive Bladder

Short‐ and long‐term efficacy of solifenacin treatment in patients with symptoms of mixed urinary incontinence

Prospective Randomized Controlled Trial of Extended-Release Oxybutynin Chloride and Tolterodine Tartrate in the Treatment of Overactive Bladder: Results of the OBJECT Study

Cognitive Effects of Oxybutynin Chloride Topical Gel in Older Healthy Subjects: A 1-Week, Randomized, Double-Blind, Placebo- and Active-Controlled Study

Advances in female stress urinary incontinence: mid‐urethral slings

Once-daily trospium chloride 60 mg extended-release provides effective, long-term relief of overactive bladder syndrome symptoms

Transdermal delivery of drugs for urologic applications: Basic principles and applications

Re: Giacomo Novara, Antonio Galfano, Silvia Secco, et al. A Systematic Review and Meta-Analysis of Randomized Controlled Trials with Antimuscarinic Drugs for Overactive Bladder. Eur Urol 2008;54:740–64

Pharmacologic Management of Overactive Bladder: Practical Options for the Primary Care Physician

Aktive Filter

Suchergebnisse filtern